Portage Biotech Inc.
PRTG
$8.10
-$1.01-11.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.79% | -68.73% | -48.80% | -56.69% | -52.32% |
| Total Receivables | -69.23% | -78.57% | 18.50% | -96.71% | -94.28% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -81.47% | -76.43% | -86.79% | -25.38% | 10.04% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.25% | -34.62% | -70.27% | -45.22% | -46.22% |
| Total Current Assets | -71.09% | -70.40% | -57.14% | -52.30% | -43.73% |
|
|
|||||
| Total Current Assets | -71.09% | -70.40% | -57.14% | -52.30% | -43.73% |
| Net Property, Plant & Equipment | -- | -- | -92.81% | -90.78% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -99.98% | -99.94% |
| Total Assets | -71.40% | -95.46% | -97.07% | -94.68% | -92.15% |
|
|
|||||
| Total Accounts Payable | -11.41% | -81.09% | -91.78% | -28.80% | 75.91% |
| Total Accrued Expenses | -71.44% | 65.00% | 47.00% | 227.50% | 48.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -42.86% | -21.28% | -- |
| Total Finance Division Other Current Liabilities | -71.74% | -- | -- | -- | 35.29% |
| Total Other Current Liabilities | -71.74% | -- | -- | -- | 35.29% |
| Total Current Liabilities | -61.79% | -59.38% | -72.16% | 13.91% | 54.37% |
|
|
|||||
| Total Current Liabilities | -61.79% | -59.38% | -72.16% | 13.91% | 54.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.81% | -86.79% | -94.83% | -98.15% | -92.85% |
| Total Liabilities | -31.42% | -82.76% | -92.08% | -86.68% | -81.25% |
|
|
|||||
| Common Stock & APIC | 1.05% | 1.05% | 0.05% | 0.03% | 0.33% |
| Retained Earnings | -2.56% | -16.85% | -41.97% | -45.57% | -49.93% |
| Treasury Stock & Other | -1.30% | 4.25% | 27.92% | 23.53% | 41.25% |
| Total Common Equity | -103.06% | -100.38% | -97.93% | -96.57% | -94.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -103.06% | -100.38% | -97.93% | -96.57% | -94.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.59% | -5.23% | -5.87% | -6.70% | -6.62% |
| Total Equity | -124.84% | -102.64% | -98.96% | -97.51% | -95.58% |
|
|
|||||